Business Description
Abpro Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US0008471031
Share Class Description:
ABPO: Ordinary SharesTotal Employee Number:
3Description
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. The company is focused on novel antibody constructs for immuno-oncology, ophthalmology, and infectious diseases. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, the company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.36 | |||||
Equity-to-Asset | -0.41 | |||||
Debt-to-Equity | -0.11 | |||||
Debt-to-EBITDA | 0.17 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 77.9 | |||||
3-Year EPS without NRI Growth Rate | 33.8 | |||||
3-Year FCF Growth Rate | 20.5 | |||||
3-Year Book Growth Rate | 58.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -58.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.61 | |||||
9-Day RSI | 56.77 | |||||
14-Day RSI | 54.25 | |||||
3-1 Month Momentum % | 80.46 | |||||
6-1 Month Momentum % | -95 | |||||
12-1 Month Momentum % | -96.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.74 | |||||
Quick Ratio | 0.74 | |||||
Cash Ratio | 0.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.5 | |||||
Shareholder Yield % | -406.94 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -1.04 | |||||
ROIC % | -109.97 | |||||
3-Year ROIIC % | -466.2 | |||||
ROC (Joel Greenblatt) % | 480.32 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.49 | |||||
EV-to-EBIT | -2.18 | |||||
EV-to-Forward-EBIT | -1.49 | |||||
EV-to-EBITDA | -1.82 | |||||
EV-to-FCF | 0.49 | |||||
Earnings Yield (Greenblatt) % | -45.87 | |||||
FCF Yield % | -496.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ABPO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abpro Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.46 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 125.89 | ||
| 14-Day RSI | 54.25 | ||
| 14-Day ATR ($) | 0.048972 | ||
| 20-Day SMA ($) | 0.203738 | ||
| 12-1 Month Momentum % | -96.56 | ||
| 52-Week Range ($) | 0.0866 - 13.65 | ||
| Shares Outstanding (Mil) | 5.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abpro Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abpro Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 156 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 65 days | ||
| General meeting for 2026 | 2026-06-26 | 0.22 (+11.43%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.21 (+6.71%) | ||
| Annual report for 2025 | 2026-04-15 | 0.12 (-25.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 5.89 (-0.42%) | ||
| 0.0333333:1 Stock Split | 2025-11-03 | 5.47 (-4.36%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 7.35 (-0.81%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 4.95 (-4.79%) |
Show
Entries
Abpro Holdings Inc Frequently Asked Questions
What is Abpro Holdings Inc(ABPO)'s stock price today?
The current price of ABPO is $0.22. The 52 week high of ABPO is $13.65 and 52 week low is $0.09.
When is next earnings date of Abpro Holdings Inc(ABPO)?
The next earnings date of Abpro Holdings Inc(ABPO) is 2026-08-31 Est..
Does Abpro Holdings Inc(ABPO) pay dividends? If so, how much?
Abpro Holdings Inc(ABPO) does not pay dividend.
Guru Commentaries on OTCPK:ABPO
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Abpro Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers